Related references
Note: Only part of the references are listed.Fifteen years after Wingspread - Environmental endocrine disrupters and human and wildlife health: Where we are today and where we need to go
Andrew K. Hotchkiss et al.
TOXICOLOGICAL SCIENCES (2008)
Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells
RF Cantón et al.
TOXICOLOGICAL SCIENCES (2005)
A stepwise approach for defining the applicability domain of SAR and QSAR models
S Dimitrov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors
M Numazawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors
F Leonetti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells
JT Sanderson et al.
TOXICOLOGICAL SCIENCES (2004)
Looking for selectivity among cytochrome P450s inhibitors
A Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Estrogen production and action
LR Nelson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
A new class of nonsteroidal aromatase inhibitors:: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase
M Recanatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors
A Cavalli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Share Paper
